Board Members

As of June 29, 2022

Members of the Board

Akira Uehara

Chief Executive OfficerAkira Uehara

Biographyopen
Apr. 1977
Joined Taisho Pharmaceutical Co., Ltd.
Jun. 1977
Member of the Board
Jun. 1978
Senior Member of the Board
Jun. 1980
Executive Vice President
Jun. 1981
Executive Vice President (Representative)
Jun. 1982
Chief Executive Officer (Representative)
Oct. 2002
Chief Executive Officer (Representative) of Taisho Toyama Pharmaceutical Co., Ltd.
Apr. 2006
Emeritus Chairman, Member of the Board
Jun. 2007
Corporate Adviser
Apr. 2009
Chairman and CEO (Representative) of Taisho Pharmaceutical Co., Ltd.
Oct. 2011
Chairman and CEO (Representative) of the Company
Jun. 2012
Chairman (Representative) of Taisho Pharmaceutical Co., Ltd.
Jun. 2013
Chief Executive Officer of the Company (present)
Jun. 2015
Chairman of Taisho Pharmaceutical Co., Ltd. (present)
Shigeru Uehara

Executive Vice PresidentShigeru Uehara

Biographyopen
Apr. 2000
Joined Taisho Pharmaceutical Co., Ltd.
May 2000
Joined Abbott Laboratories
Aug. 2006
Corporate Planning Division of Taisho Pharmaceutical Co., Ltd.
Oct. 2006
Director, Assistant to Officer in charge of Prescription Pharmaceutical Operation Group of Taisho Pharmaceutical Co., Ltd.
Oct. 2006
Deputy Head of Sales Headquarters of Taisho Toyama Pharmaceutical Co., Ltd.
Jun. 2007
Member of the Board of Taisho Toyama Pharmaceutical Co., Ltd.
Jun. 2007
Member of the Board of Taisho Pharmaceutical Co., Ltd.
Jun. 2008
Managing Member of the Board
Apr. 2009
 Executive Vice President
Oct. 2011
Executive Vice President of the Company
Jun. 2012
Chief Executive Officer (Representative) of Taisho Pharmaceutical Co., Ltd. (present)
Jun. 2013
Member of the Board of the Company
Jun. 2015
Executive Vice President of the Company (present)
Ken Uehara

Member of the BoardKen Uehara

Biographyopen
Jan. 2004
Joined Taisho Pharmaceutical Co., Ltd.
Oct. 2006
Director and Assistant to Officer in charge of Self-medication Operation Group
Apr. 2007
Deputy Head of Sales Marketing Headquarters and Deputy Head of Product Planning and Development Headquarters General Manager and Deputy General Manager
Apr. 2008
Head of Research & Development Headquarters (Self-medication), Deputy Head of Sales Marketing Headquarters and Deputy Head of Product Planning and Development Headquarters
Jun. 2008
Member of the Board
Apr. 2009
Managing Member of the Board
Oct. 2011
Managing Member of the Board of the Company
Jun. 2012
Senior Member of the Board of Taisho Pharmaceutical Co., Ltd.
Jun. 2013
Member of the Board of the Company (present)
Jun. 2014
Executive Vice President (Representative) of Taisho Pharmaceutical Co., Ltd. (present)
Jun. 2015
Member of the Board of Taisho Toyama Pharmaceutical Co., Ltd.
Jun. 2017
Chairman and Director of Biofermin Pharmaceutical Co., Ltd.
Jun Kuroda

Member of the BoardJun Kuroda

Biographyopen
Feb. 1984
Joined Taisho Pharmaceutical Co., Ltd.
Jul. 2010
Deputy Head of Overseas Business Headquarters
Oct. 2011
Director and Head of Overseas Business Headquarters
Jun. 2012
Corporate Officer and Head of International Business Headquarters
Apr. 2013
Corporate Officer of the Company
Apr. 2016
Executive Officer of Taisho Pharmaceutical Co., Ltd.
Jun. 2018
Member of the Board, Senior Executive Officer
Jun. 2021
Member of the Board of the Company (present)
Jun. 2021
Executive Vice President of Taisho Pharmaceutical Co., Ltd. (present)
Tetsu Watanabe

Member of the BoardTetsu Watanabe

Biographyopen
Apr. 1978
Joined Taisho Pharmaceutical Co., Ltd.
Oct. 2001
General Manager of Personnel and Labor Division
Jul. 2005
Director and General Manager of Personnel Division
Oct. 2008
Corporate Officer
Apr. 2013
Corporate Officer of the Company
Apr. 2013
Senior Corporate Officer of Taisho Pharmaceutical Co., Ltd.
Jun. 2015
Member of the Board of the Company (present)
Jun. 2015
Member of the Board of Taisho Pharmaceutical Co., Ltd.
Apr. 2016
Member of the Board, Executive Officer of Taisho Pharmaceutical Co., Ltd. (present)
Osamu Kitatani

Member of the BoardOsamu Kitatani

Biographyopen
Apr. 1983
Joined TOYAMA CHEMICAL CO., LTD.
Oct. 2003
General Manager of Products Management Division No.2 of Taisho Toyama Pharmaceutical Co., Ltd.
Oct. 2011
General Manager of Pharmaceutical Business Strategic Planning Division of Taisho Pharmaceutical Co., Ltd.
Apr. 2013
Director of the Company
Apr. 2015
Corporate Officer of the Company
Apr. 2015
Corporate Officer of Taisho Pharmaceutical Co., Ltd.
Jun. 2019
Chief Executive Officer of Biofermin Pharmaceutical Co., Ltd.
Apr. 2021
Executive Officer of Taisho Pharmaceutical Co., Ltd.
Apr. 2021
Chief Executive Officer of Taisho Pharma Co., Ltd. (present)
Jun. 2021
Member of the Board of the Company (present)
Jun. 2021
Member of the Board, Executive Officer of Taisho Pharmaceutical Co., Ltd. (present)
Takeshi Kunibe

Member of the Board (outside)Takeshi Kunibe

Biographyopen
Apr. 1976
Joined The Sumitomo Bank, Limited
Jun. 2003
Executive Officer of Sumitomo Mitsui Banking Corporation
Oct. 2006
Managing Executive Officer
Jun. 2007
Director of Sumitomo Mitsui Financial Group, Inc.
Apr. 2009
Director and Senior Managing Executive Officer of Sumitomo Mitsui Banking Corporation
Apr. 2011
President and Chief Executive Officer
Jun. 2011
Outside Director of NEC Corporation
Apr. 2017
President of Sumitomo Mitsui Financial Group, Inc.
Jun. 2017
Director President
Apr. 2019
Chairman of the Board (present)
Jun. 2019
Member of the Board (Outside) of the Company (present)
Jun. 2020
Outside Director of Komatsu Ltd. (present)
Jun. 2020
Outside Auditor of Nankai Electric Railway Co., Ltd.
Jun. 2021
Outside Director (Member of the Audit and Supervisory Committee) of Nankai Electric Railway Co., Ltd. (present)
Oct. 2021
Chairman of the Board of Sumitomo Mitsui Banking Corporation (present)
Hiroyuki Uemura

Member of the Board (outside)Hiroyuki Uemura

Biographyopen
Jun. 1991
Member of the Board of Sumitomo Marine & Fire Insurance Co., Ltd.
Jun. 1998
Chief Executive Officer (Representative)
Oct. 2001
Chief Executive Officer (Representative) of Mitsui Sumitomo Insurance Company, Limited
Jun. 2006
Outside Director of HOCHIKI CORPORATION. (present)
Jul. 2007
Standing Adviser
Jun. 2011
Audit & Supervisory Board Member (Outside) of Taisho Pharmaceutical Co., Ltd.
Oct. 2011
Audit & Supervisory Board Member (Outside) of the Company
Apr. 2013
Senior Adviser of Mitsui Sumitomo Insurance Company, Limited
Jun. 2015
Member of the Board (Outside) of the Company (present)
Apr. 2017
Emeritus Advisor (meiyo komon) of Mitsui Sumitomo Insurance Company, Limited (present)

Audit & Supervisory Board Members

Kazuya Kameo

Audit & Supervisory Board MemberKazuya Kameo

Biographyopen
Apr. 1976
Joined Taisho Pharmaceutical Co., Ltd.
Nov. 2000
Manager of First Research Office for Pharmaceutical Development
Apr. 2001
Manager of Research Office for Medicinal Chemistry
Feb. 2003
Manager of Pharmaceutical Quality Assurance Promotion Office
Apr. 2004
Director and Head of Quality Assurance Headquarters
Apr. 2008
Corporate Officer and Head of Pharmaceutical and Chemicals Research Center
Jul. 2008
Deputy Head of Research Headquarters
Apr. 2010
Head of Quality Assurance Headquarters
Apr. 2015
Corporate Officer of the Company
Jun. 2015
Member of the Board of the Company
Jun. 2015
Member of the Board of Taisho Pharmaceutical Co., Ltd.
Apr. 2016
Member of the Board, Executive Officer of Taisho Pharmaceutical Co., Ltd.
Jun. 2019
Audit & Supervisory Board Member of the Company (present)
Jun. 2019
Audit & Supervisory Board Member of Taisho Pharmaceutical Co., Ltd. (present)
Takeshi Ikoma

Audit & Supervisory Board MemberTakeshi Ikoma

Biographyopen
Apr. 1981
Joined NEC Corporation
Sep. 1995
Joined Sofmap Co., Ltd.
Apr. 1998
Joined Taikisha Ltd.
Jan. 2005
Joined Taisho Pharmaceutical Co., Ltd.
Apr. 2019
General Manager of Corporate Auditors' Office of the Company
Apr. 2019
General Manager of Corporate Auditors' Office of Taisho Pharmaceutical Co., Ltd.
Jun. 2021
Audit & Supervisory Board Member of the Company (present)
Jun. 2021
Audit & Supervisory Board Member of Taisho Pharmaceutical Co., Ltd. (present)
Chushiro Aoi

Audit & Supervisory Board Member (outside)Chushiro Aoi

Biographyopen
Mar. 1974
Executive Director and General Manager of Products Division
Jan. 1982
Managing Director and Head of Products Headquarters
Oct. 1984
Managing Director and Head of Central Sales Headquarters
Jan. 1994
President (Representative) of AIM CREATE Co., Ltd.
Apr. 1997
President (Representative) of MOVING CO., LTD.
Apr. 2006
Adviser
Jan. 2010
President (Representative) of Toshima Kogyo Co., Ltd. (current: A-TOM Co., Ltd.) (present)
Jun. 2015
Audit & Supervisory Board Member (Outside) of the Company (present)
May. 2019
Chairman (Representative) of A-TOM Co., Ltd. (present)
Makoto Matsuo

Audit & Supervisory Board Member (outside)Makoto Matsuo

Biographyopen
Apr. 1975
Admitted to the bar (Dai-Ichi Tokyo Bar Association)Joined Ozaki & Momo-o
May. 1978
Graduated from Columbia University, Law School
Aug. 1978
Joined Weil, Gotshal & Manges LLP in New York
Mar. 1979
Admitted to the New York Bar
Apr. 1989
Founded Momo-o, Matsuo & Namba
Partner of Momo-o, Matsuo & Namba (present)
Apr. 1997
Lecturer at Nihon University, College of Law: International Transaction Law
Jun. 1999
External Corporate Auditor of Victor Company of Japan, Limited
Jun. 2000
External Corporate Auditor of Billing System Corporation
Jun. 2003
External Corporate Auditor of Yamanouchi Pharmaceutical Co., Ltd.
Jun. 2004
External Director of Yamanouchi Pharmaceutical Co., Ltd.
Apr. 2005
Lecturer at Hitotsubashi University, Faculty and Graduate School of Law: World Business Law
Jun. 2007
External Director of CAPCOM CO., LTD.
Oct. 2008
External Director of JVC KENWOOD Holdings, Inc.
Jun. 2009
Outside Corporate Auditor of Toray Industries, Inc
Mar. 2014
External Corporate Auditor of Solasia Pharma K.K. (present)
Mar. 2015
Outside Director of TonenGeneral Sekiyu K.K.
Jun. 2016
External Director [Member of the Audit and Supervisory Committee] of CAPCOM CO., LTD. (present)
Jun. 2018
Outside Statutory Auditor of Sumitomo Forestry Co., Ltd. (present)
Apr. 2020
Provisional Audit & Supervisory Board Member of the Company
Jun. 2020
Audit & Supervisory Board Member (Outside) of the Company (present)